Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Ghiadoni

Showing results (11-20 of 78) with videos related to

Pageof 8
Sort By:
Journal of Cardiovascular Pharmacology|January 29, 2002
Endothelial dysfunction in hypertensionS Taddei, A Virdis, L Ghiadoni, et al.
Current Hypertension Reports|September 12, 2000
Antihypertensive drugs and reversing of endothelial dysfunction in hypertensionS Taddei, A Virdis, L Ghiadoni, et al.
Current Pharmaceutical Design|October 8, 2003
Mechanisms of endothelial dysfunction: clinical significance and preventive non-pharmacological therapeutic strategiesS Taddei, L Ghiadoni, A Virdis, et al.
Journal of Nephrology|July 1, 1997
Endothelial function in hypertensionP Mattei, A Virdis, L Ghiadoni, et al.
Hypertension (Dallas, Tex. : 1979)|January 21, 2000
Effect of the angiotensin II type 1 receptor blocker candesartan on endothelial function in patients with essential hypertensionL Ghiadoni, A Virdis, A Magagna, et al.
Circulation|September 29, 1999
Vasodilation to bradykinin is mediated by an ouabain-sensitive pathway as a compensatory mechanism for impaired nitric oxide availability in essential hypertensive patientsS Taddei, L Ghiadoni, A Virdis, et al.
Journal of Nephrology|August 6, 2000
Endothelial dysfunction in hypertensionS Taddei, A Virdis, L Ghiadoni, et al.
Hypertension (Dallas, Tex. : 1979)|January 1, 1997
Cyclooxygenase inhibition restores nitric oxide activity in essential hypertensionS Taddei, A Virdis, L Ghiadoni, et al.
Circulation|June 19, 1998
Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertensionS Taddei, A Virdis, L Ghiadoni, et al.
Current Pharmaceutical Design|June 17, 2010
Cigarette smoking and hypertensionA Virdis, C Giannarelli, M Fritsch Neves, et al.
Pageof 8

Showing results (11-20 of 78) with videos related to

Sort By:
Pageof 8
Journal of Cardiovascular Pharmacology|January 29, 2002
Endothelial dysfunction in hypertensionS Taddei, A Virdis, L Ghiadoni, et al.
Current Hypertension Reports|September 12, 2000
Antihypertensive drugs and reversing of endothelial dysfunction in hypertensionS Taddei, A Virdis, L Ghiadoni, et al.
Current Pharmaceutical Design|October 8, 2003
Mechanisms of endothelial dysfunction: clinical significance and preventive non-pharmacological therapeutic strategiesS Taddei, L Ghiadoni, A Virdis, et al.
Journal of Nephrology|July 1, 1997
Endothelial function in hypertensionP Mattei, A Virdis, L Ghiadoni, et al.
Hypertension (Dallas, Tex. : 1979)|January 21, 2000
Effect of the angiotensin II type 1 receptor blocker candesartan on endothelial function in patients with essential hypertensionL Ghiadoni, A Virdis, A Magagna, et al.
Circulation|September 29, 1999
Vasodilation to bradykinin is mediated by an ouabain-sensitive pathway as a compensatory mechanism for impaired nitric oxide availability in essential hypertensive patientsS Taddei, L Ghiadoni, A Virdis, et al.
Journal of Nephrology|August 6, 2000
Endothelial dysfunction in hypertensionS Taddei, A Virdis, L Ghiadoni, et al.
Hypertension (Dallas, Tex. : 1979)|January 1, 1997
Cyclooxygenase inhibition restores nitric oxide activity in essential hypertensionS Taddei, A Virdis, L Ghiadoni, et al.
Circulation|June 19, 1998
Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertensionS Taddei, A Virdis, L Ghiadoni, et al.
Current Pharmaceutical Design|June 17, 2010
Cigarette smoking and hypertensionA Virdis, C Giannarelli, M Fritsch Neves, et al.
Pageof 8